BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Johnson & Johnson (JNJ) Prostate Cancer Drug So Effective Trial Stopped


6/4/2012 7:01:00 AM

A new study shows that Johnson & Johnson‘s prostate cancer pill Zytiga dramatically slows the progression of the disease in men who are not yet sick enough to start chemotherapy. Zytiga is already approved for use in patients after chemotherapy including the drug Taxotere has been given. J&J had announced that the study was positive in April after an independent committee said it was no longer ethical to give some patients placebo. J&J is releasing full results today at the annual meeting of the American Society of Clinical Oncology in Chicago. In the 1,088-patient clinical trial, patients who received a combination of Zytiga and the steroid prednisone were 57% less likely to see their cancer advance based on a measure called radiographic progression free survival (rPFS), a more exacting version of the progression free survival (time without the tumor growing) measure used in earlier prostate cancer studies.

Read at Forbes
Read at Fox News
Read at Seeking Alpha
Read at Chicago Tribune
Read at SF Gate


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->